FDA clears blood clot detection device

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Medical Compression Systems has received FDA clearance to market its ActiveCare+Dx device developed on the basis of its flagship product, ActiveCare+S.F.T.

The new product integrates venous obstruction prevention and detection capacities with both operations carried out simultaneously during prophylactic therapy. This device detects venous obstructions in the patient's circulatory system as they occur and provides alerts about their formation, according to the West Hills, Calif.-based developer of non-invasive medical devices.